Overall Status

Completed (15)

Terminated (4)

Recruiting (3)

Unknown status (3)

Withdrawn (2)

Active, not recruiting (1)

Not yet recruiting (1)

Phase

phase 1 (8)

phase 2 (7)

phase 1/phase 2 (6)

n/a (4)

early phase 1 (1)

phase 2/phase 3 (1)

phase 4 (1)

Study Documents

Intervention Type

drug (20)

biological (8)

radiation (4)

procedure (3)

other (2)

Funder Type

Other (21)

Industry (5)

NIH (3)

Study Type

Interventional (28)

Observational [Patient Registry] (1)

non hodgkin's lymphoma

Showing 26 - 29 of 29

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Non Hodgkin's Lymphoma Trial in Busan, Seoul, Ulsan (Busulfan, Etoposide, Cytarabine, Melphalan)

Unknown status

Non Hodgkin's Lymphoma

Busulfan, Etoposide, Cytarabine, Melphalan

Busan, Korea, Republic of
+4 more

Dec 1, 2010

Chemo-Induced Nausea and Vomiting, Non Hodgkin's Lymphoma Trial in Modena (Palonosetron)

Completed

Chemotherapy-Induced Nausea and Vomiting
Non Hodgkin's Lymphoma

Palonosetron

Modena, Italy

Gruppo Italiano Studio Linfomi

Nov 24, 2009

Non Hodgkin's Lymphoma Trial (Low dose total body irradiation)

Completed

Non Hodgkin's Lymphoma

Low dose total body irradiation

(no location specified)

Feb 2, 2009

Hodgkin's Disease, Non Hodgkin's Lymphoma Trial run by the NCI (PBSC, IL-2, EPOCH II)

Completed

Hodgkin's Disease
Non Hodgkin's Lymphoma

PBSC
+2 more

Bethesda, Maryland

National Cancer Institute (NCI)

Mar 3, 2008